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Abstract
Cystic fibrosis (CF) airways disease represents an example of polymicrobial infection whereby different bacterial species can
interact and influence each other. In CF patients Staphylococcus aureus is often the initial pathogen colonizing the lungs
during childhood, while Pseudomonas aeruginosa is the predominant pathogen isolated in adolescents and adults. During
chronic infection, P. aeruginosa undergoes adaptation to cope with antimicrobial therapy, host response and co-infecting
pathogens. However, S. aureus and P. aeruginosa often co-exist in the same niche influencing the CF pathogenesis. The goal
of this study was to investigate the reciprocal interaction of P. aeruginosa and S. aureus and understand the influence of P.
aeruginosa adaptation to the CF lung in order to gain important insight on the interplay occurring between the two main
pathogens of CF airways, which is still largely unknown. P. aeruginosa reference strains and eight lineages of clinical strains,
including early and late clonal isolates from different patients with CF, were tested for growth inhibition of S. aureus. Next, P.
aeruginosa/S. aureus competition was investigated in planktonic co-culture, biofilm, and mouse pneumonia model. P.
aeruginosa reference and early strains, isolated at the onset of chronic infection, outcompeted S. aureus in vitro and in vivo
models of co-infection. On the contrary, our results indicated a reduced capacity to outcompete S. aureus of P. aeruginosa
patho-adaptive strains, isolated after several years of chronic infection and carrying several phenotypic changes temporally
associated with CF lung adaptation. Our findings provide relevant information with respect to interspecies interaction and
disease progression in CF.
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Introduction
Chronic airway infections and inflammation cause progressive
lung disease and are the leading causes of mortality in patients
with cystic fibrosis (CF) [1]. CF disease is characterized by the
accumulation of secretion in the lungs and by a decreased
mucociliary clearance that lead to an impaired ability to defeat
bacterial infections. The viscous CF lung secretions provide an
environment that protects bacteria from the assault of antibiotics
and immune cells, thus favoring colonization and persistence. CF
patients have a unique set of bacterial pathogens that are
frequently acquired in an age dependent sequence [2]. The most
frequently cultured organisms from the respiratory tract of young
children are Staphylococcus aureus and non-typeable Haemophilus
influenzae. Later, as the patient ages, infection progresses to involve
opportunistic pathogens such as Pseudomonas aeruginosa and
Burkholderia cepacia.
It is now becoming clear that the different bacteria coexisting in
CF airways have a mutual interaction and contribute to the
pathogenesis of the disease [3,4]. In a context that involves a
complex polymicrobial community a single-species microbial
analysis could be inadequate, as different microbes within the
community can interact each other and the resulting infection
pathogenesis differs from that in infections caused by the
component species individually [3,5]. Chronic bacterial infections
associated with CF lung disease have been studied by a range of
culture-independent profiling methodologies [6–12], and each
approach has revealed greater microbial diversity than was
previously recognized. Overall, the results of these studies suggest
that the polymicrobial nature of CF infections could play a key
role in driving disease and response to therapy and, in turn,
significantly impact upon clinical outcomes [1,7,13]. Nevertheless,
very little is known about the role of interspecies interactions in the
pathogenesis of the CF lung disease [14,15].
The Gram-positive bacterium S. aureus is the pathogen most
commonly isolated in nasopharyngeal samples from young
children with CF, and in the preantibiotic era, many CF patients
succumbed to S. aureus infection [16]. Recent data demonstrate an
increase in S. aureus infections in the CF population, not only in the
US but also in Europe, with methicillin-resistant S. aureus (MRSA)
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e89614
strains being on the rise [17,18], reflecting the overall increase in
prevalence and epidemiologic changes in the general population
[19,20].
Of the multiple opportunistic bacteria that may infect CF
patients, the Gram-negative bacterium P. aeruginosa is considered
to be the most significant as it has clearly been linked to worsening
of the pulmonary status [21]. Despite intensive antibiotic
treatments, P. aeruginosa infections are difficult to eradicate [22].
The antibiotic treatment may favor the emergence of antimicro-
bial drug resistance. One of the most striking characteristics of P.
aeruginosa chronic lung infection in CF patients is indeed the co-
existence of multiple phenotypes that are highly resistant to any
chemotherapy treatment [23].
Although S. aureus colonization/infection usually precedes
chronic colonization of the respiratory tract by P. aeruginosa, it
continues into adulthood, when 51% of patients become culture
positive for S. aureus [24]. Both organisms are commonly co-
isolated from CF respiratory cultures and it has been shown that
risk factors for initial P. aeruginosa airway infection in patients with
CF include S. aureus pre-colonization [25,26]. In addition, both
species are able to shift between a planktonic (free-living) life style
to surface-attached communities known as biofilms during chronic
infections. In human diseases including CF, biofilm-related
infections are directly correlated with dramatic increases in
antibiotic resistance [27,28,29].
In this study, we aimed to explore the interactions between S.
aureus and P. aeruginosa by using in vitro and murine models of
pneumonia. During chronic infection, P. aeruginosa undergoes
numerous selective pressures ranging from antibiotic treatments,
host immune response and interactions with other microorganisms
leading to the development of patho-adaptive lineages. The
adaptation of P. aeruginosa to the CF niche selects for clones with
reduced virulence in multi-hosts models [23,30]. We focused our
attention on the reciprocal influence of P. aeruginosa and S. aureus
and on understanding how P. aeruginosa adaptation to the CF lung
may interfere with S. aureus interaction. Using a collection of
longitudinal strains isolated from CF patients, we showed that P.
aeruginosa strains out-competed S. aureus. This effect was associated
with P. aeruginosa early strains, which in acute infection present
higher virulence. On the contrary, P. aeruginosa late adapted strains
showed reduced or abolished capacity to outcompete S. aureus.
This work provides key results on lung pathogenicity caused by
multi-bacterial infection.
Results
P. aeruginosa early and late clonal variants differently
influence growth of S. aureus
Eight lineages of P. aeruginosa strains, including 12 early (early
group) and 12 late (late group) clonal isolates from different
patients with CF were tested for growth inhibition of S. aureus
Newman and SH1000 strains on agar surfaces [25]. In particular,
late P. aeruginosa strains selected for this study were collected over a
period of 16.3 years and carried several patho-adaptive traits,
including mucoid and hypermutable phenotypes (Table 1) as
reported previously [23,31]. In addition, PAO1 and PA14 P.
aeruginosa reference strains, which show phenotypic traits charac-
teristic of early isolates [23], were also included.
As shown in Table 1, growth of S. aureus Newman and SH1000
strains was inhibited by PA14 and PAO1 P. aeruginosa reference
strains and by 100% (12/12) and 91.6% (11/12) of P. aeruginosa
early strains respectively in co-culture. The only exception was the
strain KK1 which was previously described as different in terms of
virulence potential from KK2, isolated at the same time point
[23]. The strength of inhibition of S. aureus in some cases differed
within clonal lineages (TR1 vs TR2; MF1 vs MF2; KK1 vs KK2).
Differently from P. aeruginosa early strains, 58.4% (7/12) of the
late strains had no effect on growth of S. aureus Newman and
SH1000 strains. These P. aeruginosa strains belonged to six different
lineages (NN, BT, AA, TR, MF, KK) indicating presence of at
least one P. aeruginosa strain unable to inhibit S. aureus growth in the
majority of CF patients (75%: 6/8). The other two P. aeruginosa
lineages (SG and BST) (25%: 2/8) inhibited S. aureus growth
although to a lesser extent when compared to early strains. Late P.
aeruginosa strains within the same lineage also differed with regard
to the strength of S. aureus growth inhibition (SG57 vs SG58; BT72
vs BT73; TR66 vs TR67), indicating a diversification of the
bacterial population during chronic infection as demonstrated for
other virulence traits [23,32]. The average inhibition halo of late
group was 11.6 mm versus Newman and 11.3 mm versus
SH1000, while the average inhibition halo of early group was
18.3 mm versus Newman and 17.4 mm versus SH1000. Late
group showed a statistically significant effect in reducing levels of
inhibition (regression parameter =26.76 versus Newman and
regression parameter =26.24 versus SH1000) with p,0.01 for
both settings. This data indicated that, as a group, late P. aeruginosa
strains differ significantly from early strains in their capacity to
inhibit S. aureus growth, suggesting a trend of P. aeruginosa patho-
adaptive variants to influence the growth of S. aureus.
On the contrary S. aureus did not exert any effect on the growth
of P. aeruginosa (Table S1).
Competition between S. aureus and P. aeruginosa in
planktonic co-cultures
Next, we investigated the interactions between S. aureus and P.
aeruginosa in planktonic growth by comparing the growth kinetics of
the two organisms in co-culture to those obtained in pure culture.
One reference P. aeruginosa strain PA14 and a pair of sequential
strains from patient AA were selected. Figure 1A shows the growth
curves of the reference S. aureus Newman and P. aeruginosa PA14
strains in single and dual cultures. PA14 maintained the same
growth rate in pure culture and in co-culture, and had a significant
negative effect on the overall trend of the growth of Newman
(p,0.001). In order to have a clear comprehension of the
differences in growth between S. aureus and P. aeruginosa, we
calculated the Competition Index (CI), that allows to compare the
differences in growth curve of mixed cultures, and the CI-like
index, the Relative Increase Ratio (RIR), that compares the
growth curves of the two species in pure culture (see Materials and
Methods). As shown in Figure 1B, the CI of PA14 versus Newman
was significantly different from the RIR in late exponential phase
(12 h, p,0.001) and stationary phase (24 h, p,0.001) of growth,
suggesting an inhibitory effect of P. aeruginosa on S. aureus.
Next, we explored the effect of P. aeruginosa strains isolated at the
onset of chronic colonization (early strains) or several years after
acquisition (late strains) from CF patients on growth of S. aureus. A
pair of well characterized P. aeruginosa clonal strains isolated from
CF patient were selected: the AA2 early strain and AA43 late
adapted strain carrying several phenotypic changes in virulence
factor production, and patho-adaptive mutations within the
genome temporally associated with CF lung infection [23,30,33].
The growth of Newman was significantly inhibited by the presence
of the early AA2 strain (p,0.001), while AA2 strain was not
affected from the presence of S. aureus (Figure 1C). The CI of AA2
versus Newman was significantly higher than the RIR in late
exponential phase (8 h, p,0.05 and 12 h, p,0.01, Figure 1D) and
in stationary phase (24 h, p,0.01). On the other hand, Newman
and the late strain AA43 interfered each other in co-culture,
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slightly but significantly reducing their growth rate compared to
pure culture (p,0.001, Figure 1E). It is worth noting that AA43
inhibited the growth of Newman to a lower extent compared to
AA2: while AA2 determined a reduction of 3, 5 and 6 log at 8, 12
and 24 h respectively, AA43 determined a reduction of less than 1
log at the same time points (Figure 1C and E). Being the
competition reciprocal between the two species and considering
their different growth rate in pure culture, the CI did not differ
from the RIR (Figure 1F). Similar results were obtained using the
same isolates of P. aeruginosa, AA2 and AA43, in co-culture with the
reference S. aureus SH1000 (Figure S1) strengthening the results
obtained with Newman. Taken together these data indicate that P.
aeruginosa strains, including reference or those isolated at the early
stage of chronic infection, can outcompete S. aureus in planktonic
cultures. On the other hand, P. aeruginosa patho-adaptive strains
lose this capacity over time.
S. aureus and P. aeruginosa interaction in biofilm
In order to understand if the reciprocal interaction among the
two species could affect their capacity to produce biofilm, we
quantified the biofilm biomass of individually cultured or co-
cultured at a ratio 1:1 S. aureus and P. aeruginosa by staining with
crystal violet. As shown in Figure 2, the results obtained from co-
cultured pair of strains formed by Newman and PA14 revealed
significantly lower level of biomass compared to Newman only
(Newman vs Newman+PA14 p,0.01), but similar to that
corresponding to PA14 alone. This data suggests an inhibitory
effect exerted by P. aeruginosa on S. aureus biofilm formation. For
clinical P. aeruginosa strains, while the OD value detected in the
mixed biofilm formed by Newman and AA2 was not significantly
different from both Newman and AA2 individually cultured, the
OD value associated to the mixed biofilm formed by Newman and
AA43 revealed significantly lower levels of biomass compared to
both Newman (Newman vs Newman+AA43 p,0.001) and AA43
(AA43 vs Newman+AA43 p,0.001) individually cultured. This
finding suggests a reciprocal interference of the two species,
confirming the results of batch co-culture experiments.
We also determined the amount of viable bacteria of each
species in both planktonic and sessile fractions in single and dual
cultures. In co-culture, we noticed that all strains of P. aeruginosa
Table 1. In vitro growth inhibition of S. aureus and P. aeruginosa.
P. aeruginosa spot S. aureus lawn (Newman) (inhibition halo) S. aureus lawn (SH1000) (inhibition halo)
PAO1 strong (24.5 mm) strong (20 mm)
PA14 strong (22 mm) strong (19 mm)
SG1 strong (23.5 mm) strong ( 22.5 mm)
SG57* strong (23 mm) strong (20.5 mm)
SG58* weak (14.5 mm) weak (15 mm)
NN2 weak (15 mm) weak (14 mm)
NN83#* no (9 mm) no (9 mm)
BT1# weak (15 mm) weak (14.5 mm)
BT2 weak (15 mm) weak (15 mm)
BT72* no (9 mm) no (9 mm)
BT73* weak (13.5 mm) weak (13 mm)
AA2 very strong (27 mm) strong (20.5 mm)
AA43* no (9 mm) no (9 mm)
TR1 weak (13.5 mm) weak (13.5 mm)
TR2 strong (20 mm) strong (20 mm)
TR66* weak (11.5 mm) weak (11.5 mm)
TR67* no (9 mm) no (9 mm)
MF1 weak (15 mm) strong (21 mm)
MF2# strong (21 mm) strong (18.5 mm)
MF51* no (9 mm) no (9 mm)
KK1 weak (12 mm) no (9 mm)
KK2 very strong (27 mm) very strong (26.5 mm)
KK71* no (9 mm) no (9 mm)
KK72* no (9 mm) no (9 mm)
BST2 weak (15 mm) weak (14.5 mm)
BST44#* weak (14.5 mm) weak (12.5 mm)
Twenty-four P. aeruginosa isolates were collected from eight individuals with CF (SG, NN, BT, AA, TR, MF, KK, BST) at the onset of chronic colonization (numbered 1-2) or
after 4.5–16.3 years of colonization (numbered 43-83). PAO1 and PA14 were included as reference strains. 5 ml spots of P. aeruginosa overnight cultures, normalized to
0.5 OD, were added to S. aureus lawn (normalized to 0.5 OD) on Mueller-Hinton agar and incubated overnight at 37uC. The table summarizes the results obtained: ‘‘weak
inhibition’’ indicates an inhibition halo #15 mm; ‘‘strong inhibition’’ indicates an inhibition halo .15 mm and #25 mm; ‘‘very strong inhibition’’ indicates an inhibition
halo .25 mm; ‘‘no inhibition‘‘ indicates absence of inhibition halo (9 mm is the diameter of the P. aeruginosa spot).
* Indicates mucoid phenotype.
#Indicates hypermutable phenotype. For statistical analysis see ‘‘Results’’.
doi:10.1371/journal.pone.0089614.t001
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tested determined a reduction of the number of both sessile and
planktonic Newman cells (p,0.001) (Figure 3A). In particular, the
bacterial load of Newman in sessile fraction, when co-cultured
with clinical early P. aeruginosa AA2, decreased of five log
compared to pure culture, while the clonal late strain AA43
caused a lower (two log) reduction. A similar effect was observed
also in planktonic fraction (Figure 3A) in agreement with batch co-
culture data.
On the contrary, the presence of Newman had no effect on
PA14 and AA2 growth in both planktonic and biofilm fractions,
while it moderately inhibited the attachment to polystyrene and
biofilm formation of the late P. aeruginosa strain AA43, confirming a
reciprocal interaction between Newman and AA43 (Figure 3B,
p,0.001).
Figure 4 shows the percentage of planktonic and sessile cells of
the two species in single and dual cultures. While Newman in pure
culture presented the highest percentage of sessile cells, in dual
culture was negatively affected by the presence of PA14 and AA2,
and the biofilm composition of the co-culture reflected that of P.
aeruginosa in pure culture (Figure 4A and 4B). A reciprocal
influence was evident only for the pair represented by Newman
and the late strain AA43 (Figure 4C). It is worth noting that in
single species biofilm, the mucoid AA43 strain, even if apparently
displaying a lower biofilm biomass compared to AA2 after staining
with crystal violet, presented a higher percentage of sessile cells
compared to AA2 (5.7% vs 3.4% respectively).
Competition between P. aeruginosa and S. aureus in a
mouse model of acute lung infection
To test whether the observed differences in planktonic growth
and biofilm formation in vitro would be relevant in vivo, a mouse
model of acute pneumonia was used. Thus, we set up in vivo
competition between P. aeruginosa and S. aureus in C57Bl/6NCrlBR
mice challenged with 16106 CFU of S. aureus and P. aeruginosa
strains mixed together at a 1:1 ratio. Eighteen hours after
infection, murine lungs were homogenized and plated. Differential
CFU counting was performed to calculate the CI. Results show
that P. aeruginosa reference strain PA14 and the early isolate AA2
outcompeted S. aureus strain Newman, as the CI, being signifi-
cantly different from 1, indicated a competitive advantage of P.
aeruginosa over S. aureus (PA14/Newman average CI = 5.0, p,0.01;
AA2/Newman average CI = 3.3, p,0.05). Different results were
obtained for the P. aeruginosa late isolate AA43 and Newman as the
CI 18 hours after challenge was not significantly different from 1
(AA43/Newman CI = 0.9), indicating no competition in this case
(Figure 5 and Table 2).
Discussion
The goal of this study was to investigate the influence of P.
aeruginosa adaptation to the CF lung on interaction with S. aureus in
co-culture, during biofilm formation and mouse lung infection, in
order to gain important insight on the interplay occurring between
the two main pathogens of CF airways, which is still largely
unknown. For this purpose, we used a panel of deeply genetically
and phenotypically characterized P. aeruginosa clonal strains
isolated from CF patients at different time points during CF
chronic lung infection [33,34].
We evaluated the inhibitory effect of eight P. aeruginosa lineages
on S. aureus, including strains isolated both at early and late stage of
chronic infection. A negative effect on S. aureus growth significantly
associated with early-infecting P. aeruginosa strains was observed,
while clonal late-infecting P. aeruginosa strains presented a
significantly reduced or abolished virulence when co-cultivated
with S. aureus. During chronic infection, P. aeruginosa undergoes
adaptation to the CF lung, leading to patho-adaptive lineages that
differ genotypically and phenotypically from the originally
infecting strain. Such microevolution usually determines loss of
motility, acquisition of mucoidy, antibiotic resistance and loss-of-
function mutations in virulence genes, suggesting attenuation of
virulence for CF adapted strains [30,35,36,37]. Here we demon-
strated for the first time that P. aeruginosa virulence traits affect also
the interaction with other CF-related pathogen as S. aureus. As
described for other traits, intra-clonal variation was observed both
in clonal P. aeruginosa early strains and late strains isolated at the
same time from the CF patients. One of the most striking
Figure 1. Single and dual species batch growth curves and competition index values. S. aureus strain (Newman) and P. aeruginosa strains
(PA14 and two clinical early and late isolates from a CF patient AA2 and AA43) were grown for 24 hours in BHI in single culture and in co-culture after
inoculation at equal ratio from mid-exponential phase pure cultures. Growth rate was monitored by colony count after plating on selective media for
both species. Results are represented as the mean of values obtained from three independent experiments. The error bars indicate the standard
deviations. A nonlinear mixed-effect model was fitted, using a four-parameters logistic regression function. Panel A: growth curves of Newman in
pure culture and in co-culture with PA14; Panel B: Competition index (CI) and Relative Increase Ratio (RIR) calculated from single and dual cultures of
Newman and PA14; Panel C: growth curves of Newman in pure culture and in co-culture with AA2; Panel D: CI and RIR calculated from single and dual
cultures of Newman and AA2; Panel E: growth curves of Newman in pure culture and in co-culture with AA43; Panel F: CI and RIR calculated from
single and dual cultures of Newman and AA43. Each value represents the mean of CI and RIR values from three independent experiments and the
bars indicate standard deviation. Statistically significant differences in Student’s t test and in nonlinear mixed-effect model are indicated by symbols
when present: *: p,0.05; **: p,0.01; ***: p,0.001.
doi:10.1371/journal.pone.0089614.g001
Figure 2. Biofilm formation by S. aureus and P. aeruginosa
strains in single and dual cultures. Bacteria were grown overnight
in 96-well flat-bottom microtiter plates in NB medium at 37uC either
individually cultured or co-cultured at a 1:1 ratio. Biofilm biomass was
quantified by staining with crystal violet and absorbance measurements
at OD 595 nm. The values represent the means of three independent
experiments, and the bars indicate standard deviation. Statistically
significant differences in Student’s t test are indicated by symbols when
present: **: p,0.01; ***: p,0.001.
doi:10.1371/journal.pone.0089614.g002
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characteristics of P. aeruginosa chronic lung infection in CF patients
is the intense diversification of the bacterial population, leading to
the co-existence of multiple phenotypes that may colonize different
airways niches. Thus, the intra-clonal variation that we have
observed is most likely the result of this process of genetic
adaptation.
Under planktonic growth conditions, we have shown that both
the reference P. aeruginosa strain PA14 and the clinical early strain
AA2 strongly inhibited the growth of S. aureus during late
logarithmic phase and stationary phase, without being influenced
in their growth rate. Antagonism between microorganisms within
a community could be attributed to simple competition for limited
resources or to direct antagonistic effects [36]. There is evidence
supporting antagonism between P. aeruginosa and S. aureus.
Mashburn et al. demonstrated that P. aeruginosa can lyse S. aureus
to use the iron released for its own growth [38]. Moreover, it has
been reported that S. aureus is susceptible to an arsenal of
respiratory inhibitors generated by P. aeruginosa, such as pyocyanin,
hydrogen cyanide or alkyl-hydroxyquinoline N-oxides (HQNO),
which are able to suppress the aerobic metabolism and growth of
S. aureus [25,39]. Interestingly, the late P. aeruginosa strain AA43,
clonal to AA2, inhibited the growth of S. aureus at a lower extent,
compared to AA2 and was not able to outcompete it. Besides
being less virulent, AA43 was also negatively affected by the
presence of S. aureus as its growth rate was significantly slowed
down by S. aureus cells.
Despite the increasing interest on the crucial role of biofilm in
CF infections, interspecies interactions of different organisms in
mixed species biofilms are still poorly understood [27]. Here we
have shown that in co-culture biofilms all P. aeruginosa strains were
able to outcompete S. aureus in both sessile and planktonic fractions
and the composition of the population in mixed biofilms was
determined by P. aeruginosa, albeit to different extent. Also under
biofilm growth conditions, the clonal late P. aeruginosa strains AA43
presented a different behavior in the presence of S. aureus
compared to the early AA2 strain. In single species biofilm, the
mucoid AA43 strain, even if apparently displaying a lower biofilm
biomass compared to AA2 after staining with crystal violet,
presented a higher percentage of sessile cells compared to AA2.
This difference in biofilm production reflects the well documented
phenotypic changes occurring in P. aeruginosa during the establish-
ment of chronic infection. Indeed, P. aeruginosa strains isolated from
CF patients at early stage of chronic infection are generally non-
encapsulated and express a variety of virulence factors, whereas P.
aeruginosa isolates from late stage typically lack virulence factors
and convert to a mucoid phenotype, associated with greater
biofilm formation and resistance to phagocytosis [37]. In apparent
contradiction, also the early strain AA2 was able to produce
biofilm. This could be explained considering the complexity of the
microbial interactions in the CF lung, the presence of a diverse
community of P. aeruginosa strains, and the many factors
contributing to the formation of the biofilm matrix of P. aeruginosa,
besides alginate production. In addition not all adapted isolates are
Figure 3. S. aureus and P. aeruginosa planktonic and sessile cells in single and dual cultures. Bacteria were grown overnight in 96-well flat-
bottom microtiter plates in NB medium at 37uC either individually cultured or co-cultured at a 1:1 ratio. CFU counts were determined in both
planktonic and sessile fractions. Panel A: planktonic (left) and sessile (right) cells of S. aureus strain Newman in pure culture and in co-culture with P.
aeruginosa strains PA14, AA2 and AA43. Statistically significant differences are referred to Newman in pure culture. Panel B: planktonic (left) and
sessile (right) cells of P. aeruginosa strains PA14, AA2 and AA43 in pure culture and in co-culture with S. aureus strain Newman. The values represent
the means of three independent experiments, and the bars indicate standard deviation. Statistically significant differences in non-parametric Mann–
Whitney test are indicated by symbols when present: **: p,0.01; ***: p,0.001.
doi:10.1371/journal.pone.0089614.g003
Figure 4. Percentage of planktonic and sessile cells in single and dual cultures. Bacteria were grown overnight in 96-well flat-bottom
microtiter plates in NB medium at 37uC either individually cultured or co-cultured at a 1:1 ratio. CFU counts were determined in both planktonic and
sessile fractions and the percentage of S. aureus and P. aeruginosa in the two fractions of single and dual cultures was calculated. Panel A:
percentages of planktonic and sessile cells of Newman in single culture (first histogram), PA14 in single culture (second histogram), Newman and
PA14 in ideal co-culture if the 2 species would not interfere each other (third histogram, percentages have been calculated considering the values of
the first and second histograms), and Newman and PA14 in co-culture (fourth histogram). Panel B: percentages of planktonic and sessile cells of
Newman in single culture (first histogram), AA2 in single culture (second histogram), Newman and AA2 in ideal co-culture if the 2 species would not
interfere each other (third histogram, percentages have been calculated considering the values of the first and second histograms), and Newman and
AA2 in co-culture (fourth histogram). Panel C: percentages of planktonic and sessile cells of Newman in single culture (first histogram), AA43 in single
culture (second histogram), Newman and AA43 in ideal co-culture if the 2 species would not interfere each other (third histogram, percentages have
been calculated considering the values of the first and second histograms), and Newman and AA43 in co-culture (fourth histogram). SA: S. aureus; PA:
P. aeruginosa.
doi:10.1371/journal.pone.0089614.g004
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mucoid and also early not adapted strains could produce biofilm
exploiting other biofilm matrix molecules [40]. In agreement with
data obtained in planktonic co-cultures, AA2 strongly inhibited the
growth of S. aureus in mixed biofilm, without being affected. Qazi et
al. demonstrated that factors related to biofilm formation are
down-regulated in S. aureus in response to P. aeruginosa presence,
consistently with our results [41]. Compared to AA2, P. aeruginosa
AA43 inhibited S. aureus growth at lower extent, determining a
reduction of S. aureus CFU count of about 1 and 2 log in planktonic
and sessile fractions respectively, when measured against S. aureus
individual biofilm. Moreover, the capacity to produce biofilm of
AA43 was negatively affected by the presence of S. aureus,
confirming its attenuated virulence and susceptibility to competitor
organism.
Although several studies using in vitro models demonstrated an
inhibitory effect of P. aeruginosa on the growth of also highly
virulent S. aureus strains such as USA 300, in line with our results
[27,42,43], in vivo models show contradictory results [42,44]. We
further investigated S. aureus/P. aeruginosa reciprocal interaction
setting up a murine model of acute lung co-infection. In agreement
with in vitro data, the reference strain PA14 and the early CF
clinical isolate AA2, after 18 hours of co-infection, inhibited S.
aureus, while the late CF clinical isolate AA43 did not outcompete
S. aureus.
It is known that environmental and early clinical isolates of P.
aeruginosa are equipped with a repertoire of virulence factors and,
among them, also substances with anti-bacterial activity, these
factors are selected against during the adaptation process to the CF
airways environment. The results obtained in the acute pneumo-
nia model, in which an early isolate is able to inhibit the growth of
another pathogen, while its clonal adapted strain is no longer able
to do so, strengthen the loss of anti-bacterial factors during
adaptation.
Our data underline the importance of bacterial interactions in
lung infection and in particular of the complexity of the
interactions of different pathogens that coexist in the CF airways.
However, given the genetic adaptation process of P. aeruginosa that
leads to the selection of different patho-adaptive variants,
descending from the initial infecting clone, further combinations
of clonal lineages of early and late isolates should be tested to
strengthen our in vivo data. Moreover, considering that the
adaptation process during chronic infection involves also S. aureus,
other experiments using clinical early and late S. aureus strains as
well as adapted phenotypes such as small colony variants should be
performed. Our results showing the influence of adaptation on the
reciprocal interactions between S. aureus and P. aeruginosa deserve
further investigations including the host response and the effect of
environmental conditions, such as microaerobic and anaerobic
Figure 5. Competition between P. aeruginosa and S. aureus
strains in a murine model of pneumoniae. Planktonic S. aureus
strain Newman and P. aeruginosa clinical isolates AA2 and AA43 and
reference strain PA14 were used to infect C57BL/6NCrlBR mice at a ratio
of 1:1. After 18 hours of acute infection lungs homogenates were
plated on selective plates to determine S. aureus and P. aeruginosa CFU.
Each circle represents the CI for a single animal in each group. A CI
value equal to 1 indicates equal competition of the two species; a CI
value significantly ,1 indicates a competitive advantage of S. aureus
that outcompetes P. aeruginosa; a CI value significantly .1 indicates a
competitive advantage of P. aeruginosa that outcompetes S. aureus.
Wilcoxon signed rank test of the null hypothesis that the distribution of
CI is symmetric about 1 was performed. Statistically significant
differences are indicated by symbols when present: *: p,0.05; **:
p,0.01. The data are pooled from two or three independent
experiments.
doi:10.1371/journal.pone.0089614.g005
Table 2. Colonization of murine lungs with S. aureus and P. aeruginosa reference and clinical strains in competition experiments.
PA14/Newman (n=9a) AA2/Newman (n=9a) AA43/Newman (n=9a)
Mortality, % (no. of dead/total mice) 0 (0/9) 0 (0/9) 0 (0/9)
Co-infectedb, % (no. of co-infected/
surviving mice)
89 (8/9) 100 (9/9) 78 (7/9)
P. aeruginosa infectedc, % (no. of infected/
surviving mice)
100 (9/9) 100 (9/9) 78 (7/9)
S. aureus infectedd, % (no. of infected/
surviving mice)
89 (8/9) 100 (9/9) 78 (7/9)
Total cfu/lunge 3.36104 6.76103 5.86103
P. aeruginosa cfu/lunge 2.96104 4.56103 2.76103
S. aureus cfu/lunge 4.26103 2.26103 3.16103
CIf 5.0 3.3 0.9
aPooled mice, analyzed in two independent experiments.
bCo-infected mice, surviving after 18 hours from challenge.
cNumber of pooled mice infected with P. aeruginosa after 18 hours.
dNumber of pooled mice infected with S. aureus after 18 hours.
eMedian values are reported.
fCompetition Index.
doi:10.1371/journal.pone.0089614.t002
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conditions, on pathogens interactions, using both in vitro and in vivo
models of chronic infection that better mirror the progression of
CF lung disease.
Materials and Methods
Animals and ethics statement
Animal studies were conducted according to protocols approved
by the San Raffaele Scientific Institute (Milan, Italy) Institutional
Animal Care and Use Committee (IACUC, Number 444) and
adhered strictly to the Italian Ministry of Health guidelines for the
use and care of experimental animals. All efforts were made to
minimize the number of animals used and their suffering.
Research on P. aeruginosa bacterial isolates from the individuals
with CF has been approved by the responsible physician at the CF
center at Hannover Medical School, Germany. All patients gave
informed consent before the sample collection. Approval for
storing of biological materials was obtained by the Hannover
Medical School, Germany.
Bacterial strains
For S. aureus, Newman and SH1000 reference strains, were used
in the study [45,46]. Two P. aeruginosa reference strains, PA14 [47]
and PAO1 [48], and 8 clonal lineages of P. aeruginosa clinical
strains from CF patients (AA, SG, NN, BT, TR, MF, KK, BST),
including strains isolated at the onset of chronic colonization
(early: AA2, SG1, NN2, BT1, BT2, TR1, TR2, MF1, MF2, KK1,
KK2, BST2) or several years after acquisition and before patient’s
death (late: AA43, SG57, SG58, NN83, BT72, BT73, TR66,
TR67, MF51, KK71, KK72, BST44) were used in this study [23].
Clonality of strains, assessed by Pulsed Field Gel Electrophoresis
and multiple phenotypic traits, including motility, mucoid
phenotype, LasR phenotype, and pyocyanin secretion, have been
determined and previously reported [23,32].
S. aureus growth inhibition on agar surface
S. aureus cultures (Newman and SH1000) grown overnight in
Luria-Bertani broth (LB, DifcoTM) were normalized to 0.5 OD600
and uniformly spread on Mueller-Hinton agar plate (MH,
DifcoTM) by using a cotton swab. Then 5 ml of P. aeruginosa
culture, grown overnight in LB broth and normalized to 0.5
OD600, were added to the S. aureus lawn followed by incubation
overnight at 37uC [25]. The same procedure was performed
spotting S. aureus culture on P. aeruginosa lawn. The following P.
aeruginosa clonal lineages, including early and late clinical strains,
were tested: AA, SG, NN, BT, TR, MF, KK and BST (for details
see paragraph ‘‘Bacterial strains’’). As P. aeruginosa reference strains
we used PA14 and PAO1. The inhibition score was defined as
follows: ‘‘no inhibition’’ when no halo was observed around the
spot of P. aeruginosa that measures 9 mm; ‘‘weak inhibition’’
indicated an inhibition halo #15 mm; ‘‘strong inhibition’’
indicated an inhibition halo .15 mm and #25 mm; ‘‘very strong
inhibition’’ indicated an inhibition halo .25 mm. The choice for
inhibition strength ranges was based on preliminary assays
performed using the lawn of about 30 S. aureus strains (including
both reference and clinical strains of different origin) and spotting
about 60 P. aeruginosa strains (both reference and clinical strains) on
the different lawns.
Planktonic mono-culture and co-culture growth curves
All growth curves were performed in 30 ml of nutrient-rich not
selective medium, Brain-Heart Infusion broth (BHI, DifcoTM), at
37uC with shaking (180 rpm). The following strains were tested: S.
aureus (Newman, SH1000), P. aeruginosa (PA14, AA2 and AA43).
Strains were grown overnight in BHI and subcultured in fresh
medium for 2.5 hours to reach the mid-exponential phase of
growth. Bacteria were centrifuged, pellet was resuspended in fresh
medium and the OD600 was measured to adjust the concentration
of bacteria. For co-cultures each pair of S. aureus and P. aeruginosa
strains were inoculated at equal ratio (1 OD600, optical density)
from mid-exponential phase pure cultures and incubated at 37uC
for 24 hours. Pure cultures of each organism were used for
comparative purposes. At different time points (0, 0.5, 1, 2, 3, 4, 6,
8, 12 and 24 hours), samples were taken, serially diluted in sterile
phosphate-buffered saline (PBS) and plated onto Mannitol Salt
agar (MSA, DifcoTM) and Pseudomonas Isolation agar (PIA,
DifcoTM) to discriminate the two bacterial species. The agar plates
were incubated for 24 hours at 37uC and colony forming units
(CFU) were enumerated. Each experiment was repeated three
times independently. The competition index (CI) for mixed culture
was calculated as P. aeruginosa-to-S. aureus ratio within the output
sample, divided by the corresponding ratio for the input (inoculum
at time t = 0), as described by Macho and colleagues [49]. To
allow an easier comparison between the variations observed in
single versus mixed cultures a CI-like index, the Relative Increase
Ratio (RIR) was calculated as P. aeruginosa-to-S. aureus ratio within
the output sample, divided by the corresponding ratio in the
inoculum, using growth results from pure cultures [49]. As the
RIR is calculated on the results obtained from single growth
curves, only a CI that differs statistically from the RIR of the same
time-point can be considered a result of a significant competition
between the species [49].
Biofilm production
Biofilm production in static conditions was visualized by crystal
violet (CV) staining as previously described [34]. The following S.
aureus and P. aeruginosa strains were tested: Newman, PA14, AA2
and AA43. Strains were grown overnight in Nutrient Broth (NB,
DifcoTM) and subcultured in fresh medium for 2.5 hours to reach
the mid-exponential phase of growth. Bacteria were centrifuged,
pellet was washed with PBS, resuspended in fresh medium and the
OD600 was measured to adjust the concentration of bacteria [34].
Experiments were performed in triplicate and repeated three times
independently. The data were then averaged and the standard
deviation was calculated.
To correlate the growth in the planktonic fraction with biofilm
formation, the planktonic cell fractions, which were transferred to
new microtiter plates, were quantified by plating serial dilutions on
MSA and PIA agar plates. To enumerate the sessile cells of S.
aureus and P. aeruginosa, the wells were rinsed three times with
200 ml of PBS to remove non-adherent and weakly adherent
bacteria. Then, the biofilm was removed by scraping the surface of
each well with 1 ml PBS and the recovered cells were suspended
by vortexing for 30 sec. The number of sessile cells was
determined by plating serial dilutions on MSA and PIA agar
plates. To ensure the complete detachment of the bacteria, CV
(1%) assay was performed on each of the wells scraped, and
absorbance determined at 595 nm.
Mouse model of acute lung single and co-infection
Experiment of acute infection with S. aureus and P. aeruginosa
strains were performed using C57Bl/6NCrlBR male mice (20–22
gr), purchased by Charles River, with minor modification to
previous published protocols [20,30]. For the co-infections, P.
aeruginosa referent strain PA14 and clinical isolates AA2 and AA43,
and S. aureus referent strain Newman, grown at middle exponential
phase, were recovered by centrifugation and resuspended in PBS
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to the desired sub-lethal dose for infection of 16106 CFU both for
P. aeruginosa and S. aureus and mixed together at a ratio of 1:1.
C57Bl/6NCrlBR mice were anesthetized by an intraperitoneal
injection of a solution of 2.5% Avertin (2,2,2-tribromethanol, 97%;
Sigma Aldrich) in 0.9% NaCl and administered in a volume of
0.015 mlg21 body weight. Trachea was directly visualized by a
ventral midline incision, exposed and intubated with a sterile,
flexible 22-g cannula (Becton, Dickinson, Italy) attached to a 1 ml
syringe. Co-infection was established with a 60 ml inoculum
implanted via the cannula into the lung, with both lobes
inoculated. Mice were also infected with 16106 CFU of plank-
tonic P. aeruginosa or S. aureus for comparative purposes.
After 18 hours from infection, mice were euthanized and
murine lungs were aseptically excised, homogenized and plated
onto MSA and PIA plates for differential CFU counting. The
competition index (CI) was calculated as the ratio of P. aeruginosa to
S. aureus bacteria recovered from the murine lungs after 18 hours
from infection adjusted by the input ratio that was inoculated in
each animal (in vivo CI). A CI value equal to 1 indicates equal
competition of the two species; a CI value significantly ,1
indicates a competitive advantage of S. aureus that outcompetes P.
aeruginosa; a CI value significantly .1 indicates a competitive
advantage of P. aeruginosa that outcompetes S. aureus.
Statistical analysis
In vitro agar growth inhibition data were analyzed by means of a
LME (Linear Mixed effect model) separated for Newman and
SH1000. Response variable was inhibition and covariates were
groups (early versus late) and a random effect on patient to
account for lineages heterogeneity. To analyze batch co-culture
data reported in Figure 1A, 1C, 1E the CFU/ml values were
transformed using a log10 function. Data retrieved from single and
co-culture experiments showed a similar starting point (estimated
by intercept parameter A) and different behavior in some settings
over time , leading to different plateau values (estimated by
parameter B) at the end of the follow-up period. This suggested to
use a nonlinear mixed-effect model (ref), (with the non-linearity
described by a four-parameters logistic regression function) to
estimate the log10(CFU/ml) trend, modelled as it follows: A+B/
{1+exp[(C2x)/exp(D)]}.
This kind of model is widely used for growth curve modeling.
Since the parameter A represents horizontal asymptote relative to
the starting point, we assign a random effect (representing the
heterogeneity among experiments) on this parameter to include
heterogeneity among experiments. Parameter B represents the
horizontal asymptote relative to the final plateau; we studied the
possible influence of single/co-culture (described by its indicator
variable), in order to test the hypothesis of different plateau at the
end of the follow up. This represents the main effect of interest and
its significance was tested comparing likelihood with and without
it. Parameter C is the inflection point and has been estimated using
a maximum likelihood principle. Parameter D is strictly connected
to the so called scale parameter and represents the growth rate of
the logistic function. A fixed effect common for single single and
co-culture was estimated. RIR and CI indexes were analyzed
using Student’s t-test and the null hypothesis: mean CI was not
significantly different from mean RIR [49]. In vitro biofilm data
(OD values) were analyzed using Two-tailed Student’s t-test [34].
CFU biofilm data were analyzed by means of Mann–Whitney test,
a non-parametric procedure to evaluate a null hypothesis that two
populations are the same against an alternative that one
population tends to have larger values than the other. Competition
index (CI) of in vivo experiments was calculated adapting the
methods previously published [20]. To assess bacterial competition
Wilcoxon signed rank test of the null hypothesis that the
distribution of CI is symmetric about 1 was used. Significance
was set at the usual level 0.05. All statistical analyses were
performed using R 2.15.2 (http://www.R-project.org/).
Supporting Information
Table S1 In vitro growth inhibition of P. aeruginosa.
(DOCX)
Figure S1 Single and dual species batch growth curves
and competition index values. S. aureus strain (SH1000) and
P. aeruginosa strains (PA14 and two clinical early and late isolates
from a CF patient AA2 and AA43) were grown for 24 hours in
BHI in single culture and in co-culture after inoculation at equal
ratio from mid-exponential phase pure cultures. Growth rate was
monitored by colony count after plating on selective media for
both species. Results are represented as the mean of values
obtained from three independent experiments. The error bars
indicate the standard deviations. A nonlinear mixed-effect model
was fitted, using a four-parameters logistic regression function.
Panel A: growth curves of SH1000 in pure culture and in co-
culture with PA14; Panel B: Competition index (CI) and Relative
Increase Ratio (RIR) calculated from single and dual cultures of
SH1000 and PA14; Panel C: growth curves of SH1000 in pure
culture and in co-culture with AA2; Panel D: CI and RIR
calculated from single and dual cultures of SH1000 and AA2;
Panel E: growth curves of SH1000 in pure culture and in co-
culture with AA43; Panel F: CI and RIR calculated from single
and dual cultures of SH1000 and AA43. Each value represents the
mean of CI and RIR values from three independent experiments
and the bars indicate standard deviation. Statistically significant
differences in Student’s t test and in nonlinear mixed-effect model
are indicated by symbols when present: *: p,0.05; ***: p,0.001.
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